![Michael Berendt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Berendt
Vorsitzender bei
Anchor Therapeutics, Inc.
Profil
Dr. Michael J.
Berendt is an Executive Chairman at Retension Pharmaceuticals, Inc. and an Executive Chairman at Anchor Therapeutics, Inc. Dr. Berendt was previously employed as a Director, Chief Executive & Scientific Officer by Telesta Therapeutics, Inc., a President & Chief Executive Officer by Aegera Therapeutics, Inc., a Managing Director by RCT BioVentures, a Managing Director by Research Corporation Technologies, Inc., a Managing Director by AEA Investors LP, an Independent Director by Waters Corp., a Senior Vice President-Research by Bayer Corp., a Group Director-Drug Discovery by Pfizer Inc., and a Chairman by Alethia Biotherapeutics, Inc. He also served on the board at Trillium Therapeutics, Inc. /Old/, Catalyst Bioscience, Inc. /Old/, Grifols Canada Plasma Resources, Inc., Myriad Genetics, Inc., Neomed Institute, Northstar Neuroscience, Inc. and Onyx Pharmaceuticals, Inc. He received his undergraduate degree from Ohio Dominican University, a graduate degree from Miami University and a doctorate degree from Drexel University.
Aktive Positionen von Michael Berendt
| Unternehmen | Position | Beginn |
|---|---|---|
Anchor Therapeutics, Inc.
 Anchor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Designs and develops peptide modulators of G protein-coupled receptors | Vorsitzender | - |
Ehemalige bekannte Positionen von Michael Berendt
| Unternehmen | Position | Ende |
|---|---|---|
| WATERS CORPORATION | Direktor/Vorstandsmitglied | 05.10.2021 |
| TELESTA THERAPEUTICS INC | Vorstandsvorsitzender | 01.11.2016 |
Trillium Therapeutics, Inc. /Old/
 Trillium Therapeutics, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Provides research and development of pharmaceuticals | Direktor/Vorstandsmitglied | 06.06.2014 |
Aegera Therapeutics, Inc.
 Aegera Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and develops drugs | Vorstandsvorsitzender | 01.07.2011 |
RCT BioVentures
 RCT BioVentures Investment ManagersFinance RCT BioVentures invests in companies located in the United States. The firm focuses on biotechnology, medical devices & technology sectors. It provides financing for early stage capital requirements. | Corporate Officer/Principal | 01.12.2005 |
Ausbildung von Michael Berendt
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
84
Beziehungen ersten Grades
20
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 20 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Waters Corp.
 Waters Corp. Medical SpecialtiesHealth Technology Designs, manufactures, sells and services analytical technologies: liquid chromatography, mass spectrometry, and thermal analysis | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Myriad Genetics, Inc.
 Myriad Genetics, Inc. Medical SpecialtiesHealth Technology Develops therapeutic and predictive medicine products | Health Technology |
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical, healthcare & agricultural products | Health Technology |
AEA Investors LP
 AEA Investors LP Investment ManagersFinance AEA Investors invests in middle-market companies located across the globe primarily in North America with an enterprise value of USD 400 million - 2.5 billion and an EBITDA of USD 5 - 200 million. The firm focuses on industrial & industrial services, tech-enabled business services and tech-enabled healthcare services. It participates in buyout and growth stage transactions in the form of debt and equity with an investment size of USD 50 – 150 million. The firm makes co-investments and acquires majority and minority interests. | Finance |
Telesta Therapeutics, Inc.
 Telesta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Researches and develops pharmaceutical products for the human and veterinary markets | Health Technology |
Northstar Neuroscience, Inc.
 Northstar Neuroscience, Inc. Medical SpecialtiesHealth Technology Provides solutions for stroke and other neurological diseases and disorders | Health Technology |
Catalyst Bioscience, Inc. /Old/
 Catalyst Bioscience, Inc. /Old/ Medical SpecialtiesHealth Technology Develops and markets catalytic biopharmaceutical products | Health Technology |
Anchor Therapeutics, Inc.
Anchor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Designs and develops peptide modulators of G protein-coupled receptors | Health Technology |
RCT BioVentures
RCT BioVentures Investment ManagersFinance RCT BioVentures invests in companies located in the United States. The firm focuses on biotechnology, medical devices & technology sectors. It provides financing for early stage capital requirements. | Finance |
Drexel University
 Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Miami University
 Miami University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ohio Dominican University
 Ohio Dominican University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aegera Therapeutics, Inc.
Aegera Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and develops drugs | Health Technology |
Trillium Therapeutics, Inc. /Old/
Trillium Therapeutics, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Provides research and development of pharmaceuticals | Commercial Services |
Alethia Biotherapeutics, Inc.
 Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets | Health Technology |
Research Corporation Technologies, Inc.
 Research Corporation Technologies, Inc. Financial ConglomeratesFinance Provides investment related services | Finance |
Neomed Institute
 Neomed Institute Pharmaceuticals: OtherHealth Technology Operates as a non-profit organization for pharmaceutical companies | Health Technology |
ProMetic Plasma Resources, Inc.
 ProMetic Plasma Resources, Inc. Medical/Nursing ServicesHealth Services Operates plasma donation centers | Health Services |
